FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383615290> ?p ?o ?g. }

• W4383615290 endingPage "1072" @default.
• W4383615290 startingPage "1063" @default.
• W4383615290 abstract "Although regulatory T cells (Treg) are inhibitory immune cells that are essential for maintaining immune homeostasis, Tregs that infiltrate tumor tissue promote tumor growth by suppressing antitumor immunity. Selective reduction of tumor-infiltrating Tregs is, therefore, expected to activate antitumor immunity without affecting immune homeostasis. We previously reported that selective Treg depletion targeted by a C-C motif chemokine receptor 8 (CCR8) resulted in induction of strong antitumor immunity without any obvious autoimmunity in mouse models. Thus, herein, we developed a novel humanized anti-CCR8 monoclonal antibody, S-531011, aimed as a cancer immunotherapy strategy for patients with cancer. S-531011 exclusively recognized human CCR8 among all chemokine receptors and showed potent antibody-dependent cell-mediated cytotoxicity activity toward CCR8+ cells and neutralization activity against CCR8-mediated signaling. We observed that S-531011 reduced tumor-infiltrating CCR8+ Tregs and induced potent antitumor activity in a tumor-bearing human-CCR8 knock-in mouse model. Moreover, combination therapy with S-531011 and anti-mouse programmed cell death 1 (PD-1) antibody strongly suppressed tumor growth compared with anti-PD-1 antibody alone with no observable adverse effects. S-531011 also depleted human tumor-infiltrating Tregs, but not Tregs derived from human peripheral blood mononuclear cells. These results suggest that S-531011 is a promising drug for inducing antitumor immunity without severe side effects in the clinical setting." @default.
• W4383615290 created "2023-07-09" @default.
• W4383615290 creator A5011006346 @default.
• W4383615290 creator A5019029847 @default.
• W4383615290 creator A5024225553 @default.
• W4383615290 creator A5029240002 @default.
• W4383615290 creator A5038198190 @default.
• W4383615290 creator A5042599703 @default.
• W4383615290 creator A5042814026 @default.
• W4383615290 creator A5045186633 @default.
• W4383615290 creator A5045313293 @default.
• W4383615290 creator A5048527314 @default.
• W4383615290 creator A5051283453 @default.
• W4383615290 creator A5063890473 @default.
• W4383615290 creator A5072054832 @default.
• W4383615290 creator A5076087584 @default.
• W4383615290 creator A5086387091 @default.
• W4383615290 creator A5092427812 @default.
• W4383615290 date "2023-07-07" @default.
• W4383615290 modified "2023-10-14" @default.
• W4383615290 title "S-531011, a Novel Anti-Human CCR8 Antibody, Induces Potent Antitumor Responses through Depletion of Tumor-Infiltrating CCR8-Expressing Regulatory T Cells" @default.
• W4383615290 cites W1483573531 @default.
• W4383615290 cites W1486722793 @default.
• W4383615290 cites W1820495241 @default.
• W4383615290 cites W2043133666 @default.
• W4383615290 cites W2065861447 @default.
• W4383615290 cites W2110714188 @default.
• W4383615290 cites W2120644528 @default.
• W4383615290 cites W2149864650 @default.
• W4383615290 cites W2338072361 @default.
• W4383615290 cites W2338494814 @default.
• W4383615290 cites W2552653135 @default.
• W4383615290 cites W2619366202 @default.
• W4383615290 cites W2635951006 @default.
• W4383615290 cites W2782007611 @default.
• W4383615290 cites W2805826288 @default.
• W4383615290 cites W2883725514 @default.
• W4383615290 cites W2885781276 @default.
• W4383615290 cites W2917646500 @default.
• W4383615290 cites W2941582519 @default.
• W4383615290 cites W2941616757 @default.
• W4383615290 cites W3021839180 @default.
• W4383615290 cites W3082731516 @default.
• W4383615290 cites W3113884318 @default.
• W4383615290 cites W3132092642 @default.
• W4383615290 cites W3137171679 @default.
• W4383615290 cites W3151163815 @default.
• W4383615290 cites W4200164989 @default.
• W4383615290 cites W4211033466 @default.
• W4383615290 cites W4220995220 @default.
• W4383615290 doi "https://doi.org/10.1158/1535-7163.mct-22-0570" @default.
• W4383615290 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37420296" @default.
• W4383615290 hasPublicationYear "2023" @default.
• W4383615290 type Work @default.
• W4383615290 citedByCount "1" @default.
• W4383615290 countsByYear W43836152902023 @default.
• W4383615290 crossrefType "journal-article" @default.
• W4383615290 hasAuthorship W4383615290A5011006346 @default.
• W4383615290 hasAuthorship W4383615290A5019029847 @default.
• W4383615290 hasAuthorship W4383615290A5024225553 @default.
• W4383615290 hasAuthorship W4383615290A5029240002 @default.
• W4383615290 hasAuthorship W4383615290A5038198190 @default.
• W4383615290 hasAuthorship W4383615290A5042599703 @default.
• W4383615290 hasAuthorship W4383615290A5042814026 @default.
• W4383615290 hasAuthorship W4383615290A5045186633 @default.
• W4383615290 hasAuthorship W4383615290A5045313293 @default.
• W4383615290 hasAuthorship W4383615290A5048527314 @default.
• W4383615290 hasAuthorship W4383615290A5051283453 @default.
• W4383615290 hasAuthorship W4383615290A5063890473 @default.
• W4383615290 hasAuthorship W4383615290A5072054832 @default.
• W4383615290 hasAuthorship W4383615290A5076087584 @default.
• W4383615290 hasAuthorship W4383615290A5086387091 @default.
• W4383615290 hasAuthorship W4383615290A5092427812 @default.
• W4383615290 hasBestOaLocation W43836152901 @default.
• W4383615290 hasConcept C13373296 @default.
• W4383615290 hasConcept C154317977 @default.
• W4383615290 hasConcept C159654299 @default.
• W4383615290 hasConcept C202751555 @default.
• W4383615290 hasConcept C203014093 @default.
• W4383615290 hasConcept C2777701055 @default.
• W4383615290 hasConcept C2779341262 @default.
• W4383615290 hasConcept C2780674031 @default.
• W4383615290 hasConcept C502942594 @default.
• W4383615290 hasConcept C55493867 @default.
• W4383615290 hasConcept C86803240 @default.
• W4383615290 hasConcept C8891405 @default.
• W4383615290 hasConceptScore W4383615290C13373296 @default.
• W4383615290 hasConceptScore W4383615290C154317977 @default.
• W4383615290 hasConceptScore W4383615290C159654299 @default.
• W4383615290 hasConceptScore W4383615290C202751555 @default.
• W4383615290 hasConceptScore W4383615290C203014093 @default.
• W4383615290 hasConceptScore W4383615290C2777701055 @default.
• W4383615290 hasConceptScore W4383615290C2779341262 @default.
• W4383615290 hasConceptScore W4383615290C2780674031 @default.
• W4383615290 hasConceptScore W4383615290C502942594 @default.
• W4383615290 hasConceptScore W4383615290C55493867 @default.
• W4383615290 hasConceptScore W4383615290C86803240 @default.
• W4383615290 hasConceptScore W4383615290C8891405 @default.

• next